SEC Form 4 · accession 0001127602-17-016577
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Gunnar Knell
Officer — CSVP&Chief Accounting Officer
Period of report
May 1, 2017
Accepted (ET)
May 3, 2017 · 3:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 1, 2017 | A | 830 | $0.00 | A | 830 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F2 | $90.43 | May 1, 2017 | A | 1,330 | A | May 1, 2018 | May 1, 2022 | Common Stock | 1,330 | 1,330 | D |
Explanation of responses
- F1Consists of 830 unvested restricted stock units that vest as follows: 207 shares vest one (1) year from the date of issuance, 208 shares vest two (2) years from the date of issuance, 207 shares vest three (3) years from the date of issuance and 208 shares vest four (4) years from the date of issuance.
- F2Stock options vest as follows: 332 options vest one (1) year from the date of grant, 333 options vest two (2) years from the date of grant, 332 options vest three (3) years from the date of grant, and 333 options vest four (4) years from the date of grant.